Electrodiagnostic Parameters in Patients With Impaired Glucose Tolerance and Diabetes Mellitus
A Observational Cross Sectional Study to Evaluate the Sensory Nerve Conduction Parameters of the Distal Sensory Nerves in Patients With Impaired Glucose Tolerance and Diabetes Mellitus
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this study is to evaluate the distal sensory nerves of the feet, namely, the dorsal sural, medial dorsal cutaneous and medial plantar nerves, in patients with impaired glucose tolerance and diabetes mellitus type 2 and compare these parameters to those from healthy participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 22, 2010
CompletedFirst Posted
Study publicly available on registry
March 29, 2010
CompletedMarch 29, 2010
March 1, 2010
8 months
March 22, 2010
March 26, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nerve conduction parameters
Nerve conduction study (NCS) parameters of the dorsal sural, medial dorsal cutaneous and medial plantar nerves, along with standard NCS of the tibial and peroenal motor, sural, superficial peronea, median and radial sensory nerves.
NCS performed once, within one day after enrollment
Secondary Outcomes (1)
Clinical neuropathic scoring system
once, at a single point of time, within one day after enrollment,
Study Arms (3)
IGT group
IGT diagnosed by endocrinologist
DM group
DM diagnosed by endocrinologist and whose primary NCS screening shows SNAP amplitudes of sural and superficial peroneal nerves greater than 10mA DM patients with no previous diagnosis of peripheral polyneuropathy
Normal healthy participants
Normal health participants with no previous history of DM, IGT, thyroid disorder, hypercholesterolemia, or other condition associated with peripheral polyneuropathy
Interventions
Standard NCS of the sural, superficial peroneal sensory nerves, peroneal, tibial motor nerves, radial and median sensory nerves, median motor nerves, F-wave studies of the Tibial and median nerves. NCS of the distal sensory nerves; dorsal sural Medial dorsal cutaneous and medial plantar nerves.
Eligibility Criteria
University affiliated medical center
You may qualify if:
- For the normal healthy control group
- Healthy participants with normal NCS parameters
- For the IGT group
- Men or women aged 20-70 with IGT referred by the department of endocrinology, with FBS 100-126 mg/dl, post 2 hour OTT - 140-200mg/dl,lasting more than one year.
- Patients willing to undergo NCS.
- For the DM group
- Men or women aged 20-70 with DM type II patients referred by the department of endocrinology, with no previous diagnosis of peripheral polyneuropathy and who showed SNAP amplitudes of the sural and superficial peroneal nerves above 10mA.
- Patients willing to undergo NCS.
You may not qualify if:
- No previous diagnosis of any systemic condition related to peripheral polyneuropathy (malnutrition, alcoholic hepatitis, diabetes mellitus( normal group)), no previous medication history, such as chemotherapeutics
- No symptom or sign of peripheral polyneuropathy, no history of tingling sensation, muscle weakness, or gait disturbance
- Skin lesion or swelling that would interfere with NCS conduction
- Previous diagnosis or clinical symptoms that would indicate the presence of mononeuropathy or entrapment neuropathy of the lower extremity.
- Previous trauma episode of the lower extremity
- History of alcohol ( exceeding alcohol consumption of 170g per week ) or substance abuse,
- Pregnancy
- DM group
- Presence of undiagnosed peripheral polyneuropathy determined by screening of the sural and superficial peroneal nerves.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catholic University of Medicine, College of Medicine, Bucheon St. Mary's Hospital, Department of Rehabilitation Medicine
Bucheon-si, Kyoungido, 420-717, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geun Young Park, MD, PhD
College of Medicine, Catholic University of Korea
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 22, 2010
First Posted
March 29, 2010
Study Start
June 1, 2009
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
March 29, 2010
Record last verified: 2010-03